PT-141 works by activating the melanocortin receptors in the brain, which play a role in regulating sexual behavior and arousal. It has been found to increase sexual desire and arousal in both men and women.
In clinical trials, PT-141 has been shown to be effective in treating female sexual arousal disorder and male erectile dysfunction. It has been found to increase sexual desire and improve sexual function in both men and women.
PT-141 is typically administered via injection, either subcutaneously or intranasally. It is important to note that PT-141 is not a cure for sexual dysfunction and may not work for everyone. It is also not recommended for use in individuals with a history of cardiovascular disease or uncontrolled high blood pressure.
PT-141 has also been found to have potential therapeutic applications beyond sexual dysfunction. It has been shown to have neuroprotective properties and may have potential in treating conditions such as Parkinson's disease and multiple sclerosis. It may also have potential in treating mood disorders such as depression and anxiety.